Mealey's (May 10, 2022, 2:27 PM EDT) -- CAMDEN, N.J. — The New Jersey federal judge presiding over the olmesartan multidistrict litigation on May 6 dismissed with prejudice a class action seeking to impose New Jersey’s contingency fee limits on an alleged $8.95 million in common benefit fees paid to the MDL’s lead plaintiff attorney....